Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Dunne Insider Profile
11 Followers
Michael Dunne, Director at Vaxart, holds 0.00 shares in Vaxart (Ticker: VXRT), holds 113.75K shares in Iterum Therapeutics (Ticker: ITRM), holds 0.00 shares in Durata (Ticker: DRTX). Most recently, Michael Dunne ― shares of Vaxart on ― for an estimated value of ―.
Profitable Transactions
1 out of 7 Profitable Transactions
Average Return
-15.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 27, 2021 - Jan 27, 2022
Return:+77.60%
The most profitable trade made by Michael Dunne
Michael Dunne's Trading History
Vaxart
―
Director
―
$0.00
Iterum Therapeutics
Dec 27, 2023
Director
Informative Buy
35.00K
$189.97K
Durata
Nov 18, 2014
―
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see Michael Dunne's performance on stock
You May Also Like
Michael Dunne insider profile FAQ
What is the percentage of profitable transactions made by Michael Dunne?
The percentage of profitable transactions made by Michael Dunne is 14%.
What is the average return per transaction made by Michael Dunne?
The average return per transaction made by Michael Dunne is -15.80%.
What stocks does Michael Dunne hold?
Michael Dunne holds: VXRT, ITRM, DRTX stocks.
What was Michael Dunne’s latest transaction?
Michael Dunne latest transaction was an Uninformative Buy of ―.
What was Michael Dunne's most profitable transaction?
Michael Dunne’s most profitable transaction was an Informative Sell of ITRM stock on January 27, 2021. The return on the trade was 77.60%.
What is Michael Dunne's role in Vaxart?
Michael Dunne's role in Vaxart is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.